BIRC5 and ovarian neoplasm: Although investigations on that topic are scarce, several studies suggest potential interaction of MTs with survivin, which was found to show similar pattern of overexpression and localization in OSCC lesions [76], whereas simultaneous in vitro silencing of both survivin and MT-IIA expression showed more potent effects on cell proliferation in the aggressive ovarian tumor cell lines than either alone [77].